eccogene glp 1 Innovent gets IND for oral GLP-1 agonist Eccogene Announces Positive Topline Results

Transmission patterns of C1-INH deficiency hereditary angioedema favors a wild-type male offspring: Our experience at Chandigarh, India

Patients should never adjust doses independently without medical guidance

Veljaca M, Pavic Sladoljev D, Mildner B, et al

Ngoi ra, thi gian dng trng nhanh hn, bn cng c th kt hp s dng thm serum hoc kem dng da

Eli Lilly, the company developing the weight loss pill, plans to submit it for regulatory review in 2025 for the treatment of overweight or obesity, and in 2026 for type 2 diabetes

This study discovered that bremelanotide can kill brain cancer cells (glioblastoma) grown in laboratory culture dishes without harming normal cells